This is a preview of subscription content, access via your institution.
Reference
Da Silva EN, et al. Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome. Journal of Allergy and Clinical Immunology: In Practice 1: 687-688, No. 6, Nov 2013. Available from: URL: http://dx.doi.org/10.1016/j.jaip.2013.07.004 - Australia
Rights and permissions
About this article
Cite this article
Bee venom allergy immunotherapy. Reactions Weekly 1483, 21 (2014). https://doi.org/10.1007/s40278-014-7902-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-7902-8